ロード中...
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few fractions with high single-fraction and total...
保存先:
| 出版年: | Clin Transl Radiat Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6630187/ https://ncbi.nlm.nih.gov/pubmed/31341985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2019.04.012 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|